Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms Degronimer 2 |
Target |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H47ClN10O2 |
InChIKeyCYZNLZCEQIHJMZ-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 15 Feb 2019 |